FDA continues to ride Lupin over plant failings

5th February 2020 Uncategorised 0

India’s Lupin, whose manufacturing network racked up a warning letter and at least four Form 483s last year, has gotten off to a regulatory running start in 2020 with an early Form 483 from the FDA.

More: FDA continues to ride Lupin over plant failings
Source: fierce